Faculty

Our Leadership Team:

Alan Moss Doc, AGAF, FACG, FEBG, FRCPI is a clinician-scientist with an expertise in Inflammatory Bowel Disease (IBD), and   Professor of Medicine at Boston Academy. He completed his clinical grooming at Academy College Dublin and Harvard Medical School-affiliated programs. As Interim Chief of the department of Gastroenterology and Managing director of the Crohn's & Colitis Programme at Boston Medical Center, he leads a multi-disciplinary team for IBD intendance. He has over 200 publications, and received enquiry funding from NIDDK, AGA, the Helmsley Foundation and the Crohn's & Colitis Foundation. Current inquiry interests include exosomes every bit biomarkers, microbial therapies, and vitamin-D related immunology. He has held leadership roles in the AGA and Crohn's & Colitis Foundation, and as a fellow member of scientific review boards for NIH, European Marriage and many national research agencies.

Ansu Noronha, Doctor is a clinician-scientist with an expertise in Inflammatory Bowel Diseases and an Assistant Professor of Medicine at Boston University. She completed her clinical preparation at Boston Medical Center afterwards receiving her Medico from Jefferson Medical Higher. Equally a clinician in the Crohn's and Colitis Plan at Boston Medical Center, she works as a part of a multi-disciplinary team of gastroenterologists, nutritionists, colorectal surgeons and pharmacists. Current enquiry/clinical interests include the role of the microbiome in GI atmospheric condition including IBD, is trained in fecal microbiota transplant and chromoendoscopy. She is also the Clinical Manager for the Department of Gastroenterology.

Christopher Due south. Huang, MD is Clinical Associate Professor of Medicine at Boston University School of Medicine and is Managing director of Endoscopy Services at Boston Medical Middle. He graduated from Cornell University in 1994 and so attended New Jersey Medical School (1994-1998) before completing his Internal Medicine Residency at the Brigham and Women'south Hospital. He and so completed his Gastroenterology Fellowship preparation at Boston Medical Center in 2004 and stayed on to join the faculty. His clinical interests include colonoscopy, capsule endoscopy, and therapeutic /avant-garde endoscopy techniques such as ERCP, endoscopic ultrasound, endoscopic mucosal resection, and enteral stenting. His professional person interests include endoscopy education, and he has taught at and co-directed several national endoscopy courses for first twelvemonth GI fellows. He has served on diverse institutional, local, and national committees including the the Seven Year Liberal Arts/Medical Didactics Plan Admissions Committee at Boston Academy, the Instruction Commission of the Massachusetts Gastroenterology Association, and the Training Committee of the American Club For Gastrointestinal Endoscopy.

Sharmeel K Wasan, Doctor, FACG is a clinician-educator with an expertise in Inflammatory Bowel Diseases (IBD) and an Associate Professor of Medicine at Boston University. She completed her clinical training at Boston Medical Center, the Brigham and Women'due south Hospital, and the University of Maryland. She received her BS in Biological Sciences and BA in Anthropology from Stanford University in Palo Alto, CA and received her MD from Albert Einstein College of Medicine in New York. Every bit the Fellowship Program Director for the Department of Gastroenterology and Hepatology at Boston Medical Centre, she is actively involved in the training of fellows, residents, and medical students. Her current clinical and research interests include vaccination strategies, health intendance maintenance in patients with IBD, and educational strategies in endoscopy preparation and has received research and educational grants from BU and from industry supported funding.

Robert C. Lowe, MD is a clinician-Educator with an expertise in Gastroenterology and Hepatology, and the Banana Dean of Medical Education at Boston University. He is a graduate of Harvard Medical School, trained in Internal Medicine at Brigham and Women's Infirmary, and completed his GI fellowship training at Boston Medical Center. He is the Managing director of the Gastroenterology Grade at the Boston University Schoolhouse of Medicine, as well as an Associate Clerkship director in Internal Medicine. At BMC, he is a Key Kinesthesia fellow member in the IM residency program and Director of the Medical Educational activity Pathway for internal medicine residents. He has receive numerous awards for his clinical teaching, including the Massachusetts Medical Gild Award for Excellence in Medical Student Pedagogy. Current clinical interests include viral hepatitis, autoimmune liver illness, and metabolic liver diseases. He serves nationally on the American Gastroenterological Association'due south Maintenance of Certification Committee.

Our Faculty:

Uri, Avissar, Md is a clinician-educator with an expertise in gastroenterology and liver transplant and an Banana Professor of Medicine at Boston Academy. He completed his clinical training at the Academy of Pittsburgh Medical Center and the University of Cincinnati Medical Center. He received his BS in Chemistry from Yale University in New Oasis, CT and received his MD from University of Rochester Medical Centre in NY. His clinical interests include general gastroenterology, hepatology, and liver transplant. He is actively involved in the training of fellows, residents, and medical students.

Juanita Belton, PA-C, MPH joined Boston Academy Medical Centre's Dempsey Center for Digestive Illness in 2018 as a Md Assistant in the Crohn's and Colitis Inquiry Center. She specializes in Inflammatory Bowel Disease and general GI, including IBS, GERD, and intestinal pain. Mrs. Belton received her Available of Biology from the Historically Black Higher Clark Atlanta Academy in Atlanta, Georgia. She went on to attend Boston University School of Public Health Concentrating in Maternal and Child Health. After earning her MPH, she joined BMC's Project Trust for three years providing HIV, Hep C, and STD testing and Education. She left Project Trust to attend Massachusetts College of Pharmacy and Wellness Sciences earning her Masters in Physician Assistant Studies. She has x years experience practicing as a Physician Assistant. Before bringing her skills to BMC, she previously practiced Gastroenterology and Primary Care at Cambridge Health Alliance in Everett, MA and in Correctional Medicine at Hampden Correctional Center in Western, Mass. She is currently an Instructor in Gastroenterology at Boston Academy School of Medicine and is the leader of the sections Multifariousness, Equity, and Inclusion Committee.

Charles Elation Jr., Doc, AGAF, FACP, is a clinician with expertise in H. pylori and Assistant Professor of Medicine at Boston University. He received his MD from Boston University, and did residency at Boston City Hospital, and fellowship at Boston University. He has continued to care for patients at Boston Medical Center and E Boston Neighborhood Health Center since finishing his training. He also has served on the BU Committee on Appeals and the Awards Commission.

Lizabeth K. Cline, NP, MSN received her BS in Nursing in 1982 from Boston University and her MSN from Syracuse University in 1995. Ms. Cline'south clinical focus is liver disease including fatty liver affliction and viral hepatitis. She is currently an Teacher in Gastroenterology at Boston University School of Medicine

Anna J. Craig, PA-C, is a clinician and Instructor of medicine at Boston Academy. She completed her clinical training at Rochester Institute of Engineering science. Current clinical interests include functional disorders such equally irritable bowel syndrome, use of complementary and alternative therapies in GI disorders, and nutrition.

David R. Lichtenstein, MD is the Director of Avant-garde Gastrointestinal Endoscopy at Boston Medical Center and Professor of Medicine (pending) at Boston University School of Medicine.  Dr. Lichtenstein received his medical doctorate from the University Of Pennsylvania Schoolhouse Of Medicine. He completed his internal medicine residency at Knuckles University Medical Heart and a gastroenterology fellowship at Beth Israel Hospital in Boston.  He returned to Duke University Medical Center where he served every bit a Chief Resident in Internal Medicine followed past training in interventional endoscopy. Dr. Lichtenstein is a recognized educator in the GI endoscopy community and currently serves on the ABIM Gastroenterology Board Exam Commission and is the Chair of the ASGE Applied science Commission.  He also serves on the ASGE Infection control Task Strength and Didactics Curriculum and Competencies Council.  Dr. Lichtenstein served as the past president of the New England Endoscopy Order, the Chair of the Assessment and Certification Job Force that introduced the series of STARS educational programs for the ASGE and was a old Chair of the ERCP Section for the Annual Scientific Programme Committee for Digestive Affliction Calendar week.  His research interests focus on advancing technologies for endoscopic management of circuitous GI disorders.  Nigh recently he is the principle investigator and advisory lath member for an bogus intelligence deep neural network device that will help improve adenoma detection during colonoscopy and facilitate other aspects of quality metrics in colonoscopy.  He also serves on the clinical events committee for a randomized study of patients with pancreatic cancer that uses an EUS implanted device that may let augmented doses of radiations to the main pancreatic tumor.

Michelle T. Long, Md, MSc is a physician-scientist with an expertise in Nonalcoholic fatty liver disease (NAFLD), and Associate Professor of Medicine at Boston University. She completed her clinical training at Massachusetts General Infirmary and Boston Medical Heart. Dr. Long is the Manager of the NAFLD Research Center and the Director of Clinical Inquiry for the Section of Gastroenterology and Hepatology. Her clinical and inquiry interests center on the human relationship between NAFLD and cardiovascular disease. Dr. Long is primarily interested in patient-oriented research investigating fibrosis and inflammation in patients with NAFLD and in imaging and risk stratification strategies for hepatic fibrosis. Dr. Long has projects at Boston Medical Center and at the Framingham Center Study where she is the PI of a study evaluating the prevalence and risk factors for liver fat (steatosis) and fibrosis. In Framingham, she is investigating the clinical and genetic correlates of hepatic steatosis and fibrosis as measured by transient elastography. Dr. Long receives research funding from the NIH (NIDDK), Doris Duke Charitable Foundation, Gilead Sciences, Echosens Corporation, and Boston University. She has expertise in epidemiology, visceral fat, liver imaging including computed tomography, ultrasound, and transient elastography. Dr. Long is as well a clinical hepatologist and endoscopist.  Dr. Long is additionally interested in novel therapeutics for NAFLD and Non-alcoholic steatohepatitis (NASH) and runs the clinical trials programme for the NAFLD Research Center. Her other enquiry interests include alcohol-related liver affliction, hepatitis C, outcomes in terminate-stage liver disease/cirrhosis.

Arpan Mohanty, MD is a clinical hepatologist at Boston Medical Center and an Assistant Professor of Medicine at Boston University School of Medicine. She completed  residency grooming in Internal Medicine at the Academy of Pittsburgh Medical Center and fellowship grooming in Digestive Diseases at Yale University. She is as well trained in Advanced/Transplant hepatology at Massachusetts General Hospital. Dr. Mohanty'due south enquiry focuses on end stage liver disease and its complications. She has expertise and interest in biomarker development and outcomes research in portal hypertension. Dr. Mohanty has been recognized past several awards including the American Association for the Study of Liver Diseases (AASLD) Advanced/Transplant Hepatology Accolade and AASLD Pilot Research Award. Her enquiry on biomarker development using spectroscopic markers of gut mucosal circulation is currently funded under an R21 (co-PI) from the National Constitute on Minority Health and Wellness Disparities. She serves in the Portal Hypertension education subcommittee of the AASLD.

Thomas C. Moore, Md is a clinician with an expertise in gastrointestinal motility, and an Assistant Professor of Medicine at Boston Academy. He completed his gastroenterology fellowship at Boston University School of Medicine. He completed his undergraduate studies at Yale University and received his medical degree from Johns Hopkins Schoolhouse of Medicine. His clinical interests are gastrointestinal motility disorders, gastroesophageal reflux affliction, and functional bowel disorders.

David Nunes Md, FRCPI is a clinician and clinical investigator with an involvement in liver illness and an Associate Professor of Medicine at Boston Academy.  He completed his clinical grooming at Trinity College Dublin.  He is the Managing director of the Hepatology Program at Boston Medical Center and has held prior research grants from the NIDDK, and Manufacture supported funding.  He besides has a continued express function in research including clinical outcomes related to hepatitis C treatment and non-invasive assessment of liver fibrosis.

Paul C. Schroy, Md, MPH,is Emeritus Professor of Medicine at Boston University School of Medicine with expertise in the area of colorectal cancer screening and surveillance. He has over 150 publications, and received research funding from NCI, AHRQ, CDC and ACS. Dr. Schroy's about recent research activities accept focused primarily on the development, implementation and evaluation of model programs for community-based colorectal cancer command, including: (i) exploring the role of shared decision-making equally a strategy for increasing patient participation in colorectal cancer screening; (2) better defining the epidemiology of colorectal neoplasia and the development of risk assessment tools for predicting the presence of advanced neoplasia at screening colonoscopy; (3) evaluating the feasibility and validity of novel colorectal cancer screening strategies such as stool-based Dna testing and virtual colonoscopy; (four) implementation of quality measures related to colorectal cancer screening; and (five) developing strategies to reduce the public health burden of early-onset colorectal cancer. In addition to his commitment to patient care and clinical enquiry, Dr. Schroy is a founding member and erstwhile chair of the Massachusetts Colorectal Cancer Working Group and a founding member of the National Colorectal Cancer Round table. He has served in numerous leadership positions for the Circular tabular array, including current co-chair of the Family History and Early Onset Colorectal Cancer Task Group, quondam member of the Steering Committee, one-time co-chair of the Public Educational activity Chore Grouping, former co-chair of the Screening 65+ Task Grouping, and former chair of the Nomination Committee. He is also a former member of the Steering Committee of the Massachusetts Comprehensive Cancer Prevention and Control Network, the American Cancer Society'south New England Division's Colorectal Cancer Advisory Commission and the Massachusetts Section of Public Health's Cancer Registry Advisory Committee.

Kathleen Sullivan, MA, MSN, NP is a Gastroenterology Nurse Practitioner at Boston Medical Centre and Assistant Professor of Gastroenterology at Boston University Schoolhouse of Medicine. Ms. Sullivan attended nursing schoolhouse at the MGH Institute of Health Professions and she has a Master of Arts in Clinical Mental Wellness Counseling from Lesley Academy in Cambridge, MA.  She is the 2019 recipient of a Boston University Faculty Development and Diversity Commission Grant to attend Stress Management and Resiliency Training (SMART) at the Benson-Henry Found for Mind Body Medicine at Massachusetts General Hospital.  Her clinical interests include non-pharmacological approaches to the management of functional gastrointestinal disorders such every bit IBS.  She is peculiarly interested in the use of stress reduction techniques, nutritional changes, dietary supplements, exercise, and the use of complementary medical treatments such as acupuncture in society to help her patients improve their overall health and sense of well-existence

Horst C. Weber, MD, FACG, AGAF, is a clinician-scientist with an expertise in gastrointestinal hormones, neuroendocrine tumors, and functional bowel disorders, and is Banana Professor of Medicine and Pathology and Laboratory Medicine at Boston University School of Medicine. He completed his clinical training at the Academy of Mainz, Georgetown Academy, and the National Institutes of Health. He published over 150 original reports, reviews, book capacity, and abstracts, and received research funding from the NIDDK, ACG, DoD, and the Medical Foundation. Current research interests include healthcare disparities in irritable bowel syndrome (IBS), and he has directed many CME programs on GERD and functional bowel disorders. He holds leadership roles in the ACG, and serves on Editorial boards of several biomedical journals.